Top Clinical Trials companies in India by EBITDA Margin
India
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
53.57%
|
March 31, 2024 | USD 1.29 | 2.70% |
|
India |
|
| 2 |
31.09%
|
March 31, 2024 | USD 8.61 | -1.79% |
|
India |
|
| 3 |
30.46%
|
March 31, 2024 | USD 32.88 | -0.93% |
|
India |
|
| 4 |
28.48%
|
March 31, 2024 | USD 9.86 | 2.71% |
|
India |
|
| 5 |
25.90%
|
March 31, 2024 | USD 9.20 | 2.64% |
|
India |
|
| 6 |
24.59%
|
March 31, 2024 | USD 20.71 | -0.50% |
|
India |
|
| 7 |
18.74%
|
March 31, 2024 | USD 6.91 | -0.24% |
|
India |
|
| 8 |
12.17%
|
March 31, 2024 | USD 11.23 | 1.68% |
|
India |
|
| 9 |
9.60%
|
March 31, 2024 | USD 16.75 | 0.23% |
|
India |
|
| 10 |
4.47%
|
March 31, 2024 | USD 0.59 | -0.38% |
|
India |
|
| 11 |
-160.17%
|
March 31, 2024 | USD 0.14 | 3.84% |
|
India |
|
| 12 |
-493.94%
|
March 31, 2024 | USD 1.84 | 1.24% |
|
India |
|
| 13 |
-849.05%
|
March 31, 2024 | USD 1.48 | 10.54% |
|
India |
Frequently Asked Questions
-
Which Clinical Trials company in India has the highest EBITDA Margin ?
The Clinical Trials company in India with the highest EBITDA Margin is Ind-Swift Laboratories Limited (NSE: INDSWFTLAB.NS) at 53.57%.
-
Which Clinical Trials company in India has the lowest EBITDA Margin ?
The Clinical Trials company in India with the lowest EBITDA Margin is Suven Life Sciences Limited (NSE: SUVEN.NS) at -849.05%.
-
What are the top 10 Clinical Trials companies in India by EBITDA Margin ?
The top 10 Clinical Trials companies in India by EBITDA Margin are Ind-Swift Laboratories Limited, Syngene International Limited, Dr. Lal PathLabs Limited, Vimta Labs Limited, Thyrocare Technologies Limited, Metropolis Healthcare Limited, Indegene Limited, Jubilant Pharmova Limited, Glenmark Pharmaceuticals Limited and Vineet Laboratories Limited.
-
What are the bottom 10 Clinical Trials companies in India by EBITDA Margin ?
The bottom 10 Clinical Trials companies in India by EBITDA Margin are Suven Life Sciences Limited, Sun Pharma Advanced Research Company Limited, TAKE Solutions Limited, Vineet Laboratories Limited, Glenmark Pharmaceuticals Limited, Jubilant Pharmova Limited, Indegene Limited, Metropolis Healthcare Limited, Thyrocare Technologies Limited and Vimta Labs Limited.
